Epizyme, Inc.
COMBINATION THERAPY FOR TREATING CANCER
Last updated:
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and one or more other therapeutic agents, particularly anticancer agents such as prednisone, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
23 Nov 2021
Issue date:
21 Jul 2022